IGEN to Supply Products to U.S. Air Force For the Detection of Biological Agents Thursday March 20, 8:03 am ET Air Force Expands U.S. Government's Use of IGEN's ORIGEN(R) Technology to Seventh Homeland Security Program
GAITHERSBURG, Md., March 20 /PRNewswire-FirstCall/ -- IGEN International, Inc. (Nasdaq: IGEN - News) announced today that the U.S. Air Force has purchased IGEN's testing systems for the detection of biological agents, in order to expand their ability to protect military personnel worldwide. These products are based on the IGEN's proprietary ORIGEN technology and were selected based on their significant improvement over traditional laboratory methods, including greater sensitivity, ease of use and the ability to detect select biological agents within 30 minutes. ADVERTISEMENT Over the past year, IGEN has worked closely with numerous departments within the Department of Defense and other U.S. Government agencies using ORIGEN-based products for the detection of Category A and Category B biological agents, including agents such as anthrax, staphylococcus enterotoxin B, and botulinum toxin, among others.
The biological test reagents being used by the Department of Defense are for the detection of agents or toxins in environmental samples. U.S. Army scientists at Fort Detrick, Maryland have developed biological assays designed to measure specific agents and toxins using the Company's proprietary ORIGEN technology. This technology platform now provides the U.S. Military with reliable, field-tested products that are available for use today.
"We are extremely pleased to supply the U.S. Government and U.S. Military advanced biological agent tests based on our ORIGEN technology," said Samuel J. Wohlstadter, Chief Executive Officer of IGEN International. "We believe the continued expansion of our biological testing system's use in these important Homeland Security programs underscores the value and utility of our ORIGEN technology. We look forward to continuing to work closely with these agencies to meet their evolving needs for advanced biological testing systems |